US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.

BACKGROUND:During the 2009 H1N1 pandemic, the global health community sought to make vaccine available "in developing nations in the same timeframe as developed nations." However, richer nations placed advance orders with manufacturers, leaving poorer nations dependent on the quantity and...

Full description

Bibliographic Details
Main Authors: Supriya Kumar, Sandra Crouse Quinn, Kevin H Kim, Karen M Hilyard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22412979/?tool=EBI
id doaj-cfdce9cd340846d3847a83b23efd45c6
record_format Article
spelling doaj-cfdce9cd340846d3847a83b23efd45c62021-03-03T20:30:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3302510.1371/journal.pone.0033025US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.Supriya KumarSandra Crouse QuinnKevin H KimKaren M HilyardBACKGROUND:During the 2009 H1N1 pandemic, the global health community sought to make vaccine available "in developing nations in the same timeframe as developed nations." However, richer nations placed advance orders with manufacturers, leaving poorer nations dependent on the quantity and timing of vaccine donations by manufacturers and rich nations. Knowledge of public support for timely donations could be important to policy makers during the next pandemic. We explored what the United States (US) public believes about vaccine donation by its country to poorer countries. METHODS AND FINDINGS:We surveyed 2079 US adults between January 22(nd) and February 1(st) 2010 about their beliefs regarding vaccine donation to poorer countries. Income (p = 0.014), objective priority status (p = 0.005), nativity, party affiliation, and political ideology (p<0.001) were significantly related to views on the amount of vaccine to be donated. Though party affiliation and political ideology were related to willingness to donate vaccine (p<0.001), there was bipartisan support for timely donations of 10% of the US vaccine supply so that those "at risk in poorer countries can get the vaccine at the same time" as those at risk in the US. CONCLUSIONS:We suggest that the US and other developed nations would do well to bolster support with education and public discussion on this issue prior to an emerging pandemic when emotional reactions could potentially influence support for donation. We conclude that given our evidence for bipartisan support for timely donations, it may be necessary to design multiple arguments, from utilitarian to moral, to strengthen public and policy makers' support for donations.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22412979/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Supriya Kumar
Sandra Crouse Quinn
Kevin H Kim
Karen M Hilyard
spellingShingle Supriya Kumar
Sandra Crouse Quinn
Kevin H Kim
Karen M Hilyard
US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
PLoS ONE
author_facet Supriya Kumar
Sandra Crouse Quinn
Kevin H Kim
Karen M Hilyard
author_sort Supriya Kumar
title US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
title_short US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
title_full US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
title_fullStr US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
title_full_unstemmed US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
title_sort us public support for vaccine donation to poorer countries in the 2009 h1n1 pandemic.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description BACKGROUND:During the 2009 H1N1 pandemic, the global health community sought to make vaccine available "in developing nations in the same timeframe as developed nations." However, richer nations placed advance orders with manufacturers, leaving poorer nations dependent on the quantity and timing of vaccine donations by manufacturers and rich nations. Knowledge of public support for timely donations could be important to policy makers during the next pandemic. We explored what the United States (US) public believes about vaccine donation by its country to poorer countries. METHODS AND FINDINGS:We surveyed 2079 US adults between January 22(nd) and February 1(st) 2010 about their beliefs regarding vaccine donation to poorer countries. Income (p = 0.014), objective priority status (p = 0.005), nativity, party affiliation, and political ideology (p<0.001) were significantly related to views on the amount of vaccine to be donated. Though party affiliation and political ideology were related to willingness to donate vaccine (p<0.001), there was bipartisan support for timely donations of 10% of the US vaccine supply so that those "at risk in poorer countries can get the vaccine at the same time" as those at risk in the US. CONCLUSIONS:We suggest that the US and other developed nations would do well to bolster support with education and public discussion on this issue prior to an emerging pandemic when emotional reactions could potentially influence support for donation. We conclude that given our evidence for bipartisan support for timely donations, it may be necessary to design multiple arguments, from utilitarian to moral, to strengthen public and policy makers' support for donations.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22412979/?tool=EBI
work_keys_str_mv AT supriyakumar uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic
AT sandracrousequinn uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic
AT kevinhkim uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic
AT karenmhilyard uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic
_version_ 1714822188683493376